Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-424P designates a **pseudogene** related to the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is a well-conserved and functionally critical RNA component of the major spliceosome complex involved in pre-mRNA splicing, but pseudogenes such as RNU6-424P do not encode a functional RNA product due to mutations or deletions that prevent proper expression or processing. Pseudogenes, in general, may occasionally play regulatory or antisense roles at the RNA level, particularly in plants and certain experimental models, but there is no direct evidence that RNU6-424P acts as a functional RNA, encodes protein, or serves as a therapeutic target in humans[2]. Thus, RNU6-424P is a **genomic artifact with no known biochemical or therapeutic target activity**. **Key Notes:** - "RNU6-424P" is a pseudogene, not a receptor, enzyme, transporter, or described functional target. - No established function, disease association, or biomarker value. - No interacting drugs or mechanism of action as a drug target. - Its name can be confused with functional U6 small nuclear RNA, but it specifically denotes a pseudogene, which has fundamentally different properties and relevance[2]. If you intended to inquire about functional spliceosomal U6 snRNA, its canonical name would be "U6 small nuclear RNA," a key non-coding RNA involved in spliceosome catalysis[1], but "RNU6-424P" is not such a target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 424, pseudogene (RNU6-424P).